Drug-Loss in Dispensing Process and Adhering to the Package : Phenytoin Products as Model Dosage Forms

S. Miyamoto, Y. Kohda, Masaru Suzuki, E. Sagara
{"title":"Drug-Loss in Dispensing Process and Adhering to the Package : Phenytoin Products as Model Dosage Forms","authors":"S. Miyamoto, Y. Kohda, Masaru Suzuki, E. Sagara","doi":"10.5649/JJPHCS1975.20.315","DOIUrl":null,"url":null,"abstract":"The bioavailability of phenytoin is well known to be dependent on the dosage forms as is the fact that ground tablets of phenytoin are often ordered instead of the powdered form in doctorwritten prescriptions. Studied in the present study was weight loss of the drug resulting from the dispensing process and adherence to the package.Used as model forms were three dosage forms of phenytoin: ground tablets, fine granules and powder. Simulative dispensing was performed using the conventional method in which tablets were ground with excipients, mixed with a mortar and pestle, and divided and packaged employing two kinds of packaging machines for dispensing.The extent of total weight in loss was dependent neither on the types of packaging machines, nor on the dosage forms of phenytoin except for ground tablets. For ground tablets, a large weight loss was observed in the dispensing process, with this phenomenon being caused by splashing in the packaging process. Observed with fine granules and powder was a small weight loss relative to the dispensing process and a large one involving adherence to the package. The total loss in dispensing and package adherence was found to be 6% regardless of the phenytoin dosage form.We conclude that fine granules in the powdered form of phenytoin are the most suitable dosage form because of the compositis equivalent bioavailability to the tablet form and its only slight loss in weight during the dispensing process.","PeriodicalId":17399,"journal":{"name":"Journal of the Nippon Hospital Pharmacists Association","volume":"242 1","pages":"315-320"},"PeriodicalIF":0.0000,"publicationDate":"1994-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Nippon Hospital Pharmacists Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/JJPHCS1975.20.315","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

The bioavailability of phenytoin is well known to be dependent on the dosage forms as is the fact that ground tablets of phenytoin are often ordered instead of the powdered form in doctorwritten prescriptions. Studied in the present study was weight loss of the drug resulting from the dispensing process and adherence to the package.Used as model forms were three dosage forms of phenytoin: ground tablets, fine granules and powder. Simulative dispensing was performed using the conventional method in which tablets were ground with excipients, mixed with a mortar and pestle, and divided and packaged employing two kinds of packaging machines for dispensing.The extent of total weight in loss was dependent neither on the types of packaging machines, nor on the dosage forms of phenytoin except for ground tablets. For ground tablets, a large weight loss was observed in the dispensing process, with this phenomenon being caused by splashing in the packaging process. Observed with fine granules and powder was a small weight loss relative to the dispensing process and a large one involving adherence to the package. The total loss in dispensing and package adherence was found to be 6% regardless of the phenytoin dosage form.We conclude that fine granules in the powdered form of phenytoin are the most suitable dosage form because of the compositis equivalent bioavailability to the tablet form and its only slight loss in weight during the dispensing process.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
配药过程中的药物损失和包装上的粘附:作为模型剂型的苯妥英产品
众所周知,苯妥英的生物利用度取决于剂型,因为在医生开的处方中,经常订购苯妥英碎片而不是粉状。在本研究中研究的是由于配药过程和依从包装导致的药物重量减轻。以苯妥英磨片、细颗粒和粉剂三种剂型为模型剂型。模拟配药的方法是将片剂与辅料一起磨碎,用研钵和杵混合,用两种包装机进行分装配药。总重量损失的程度既不取决于包装机器的类型,也不取决于苯妥英的剂型,除了磨碎的片剂。对于磨碎的片剂,在配药过程中观察到大量的重量减轻,这种现象是由包装过程中的飞溅引起的。观察到细颗粒和粉末相对于配药过程有一个小的重量损失,而一个大的重量损失涉及到包装的粘附性。无论何种苯妥英剂型,分配和包装依从性的总损失均为6%。我们得出结论,粉末状的细颗粒苯妥英是最合适的剂型,因为它的生物利用度与片剂形式相当,而且在配药过程中重量只有轻微的损失。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
An Analysis of Urate-Lowering Drugs Using a Prescription Database 球形吸着炭 (クレメジン原体) の胆汁酸吸着性 癌化学療法時の口内炎に対するプロスタンディン®軟膏・アルロイドG液混合製剤の有効性 Collaboration of Hospital Pharmacists with Pharmaceutical College on Evaluation of Generic Drugs : The Case of Dissolution Test of Sodium Loxoprofen Tablets A Case Report and Evaluation of Pirmenol Toxicity Appeared with Liver Injury
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1